Results 61 to 70 of about 1,021 (176)

Solution Blow Spinning: An Emerging Nanomaterials‐Based Wound‐Care Technology

Journal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 113, Issue 2, February 2025.
ABSTRACT Application of one‐dimensional nanofibers have witnessed exponential growth over the past few decades and are still emerging with their excellent physicochemical and electrical properties. The driving force behind this intriguing transition lies in their unique high surface‐to‐volume ratio, ubiquitous nanodomains, improved tensile strength ...
Md Salauddin Sk, Ruth Mwangomo, Luke Daniel, Jordon Gilmore   +3 more
wiley   +1 more source

TFC‐1326 Compound Reduces Clinical Signs of Skin Aging. Evidence From In Vitro Human Adipose and Skin Models and Pilot Clinical Trial

Journal of Cosmetic Dermatology, Volume 24, Issue 2, February 2025.
ABSTRACT Background Anti‐freeze Glycoproteins (AFGPs) were described to preserve biological materials and protect them from different stresses. Aims The effects of a synthetic anti‐freeze glycoprotein‐based compound, TFC‐1326, on human skin quality and its biological actions were studied. Methods The effects of various concentrations of TFC‐1326 on the
Géraldine Deliencourt‐Godefroy, Jocelyne Legoedec, Marion Bourdens, Noémie Juin, Linh‐Trang Nguyen, Marie‐Christine Branchet, Sylvie Boisnic, Mayoura Keophiphath   +7 more
wiley   +1 more source

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan.

, 2000
OBJECTIVE: To compare the outcome of treatment of Sudanese kala-azar patients treated under field conditions with either branded sodium stibogluconate (SSG) (Pentostam GlaxoWellcome) or generic SSG (Albert David Ltd, Calcutta, supplied by International ...
Davidson, R N, Veeken, H, Seaman, J, Ritmeijer, K   +3 more
core  

Skewing of Sodium Antimony Gluconate mediated therapy for a predominant Th1 during visceral leishmaniasis on triggering CD2 epitope to circumvent liver infection

Annals of Hepato-Biliary-Pancreatic Surgery, 2021
Introduction Visceral leishmaniasis (VL) is a macrophage associated disorder which is linked with a profound decrease in the immunotherapeutic potential of the infected subjects leading to a marked reduction in the CD4 linked Th1 protective immune response.
openaire   +2 more sources

Drug regimen adopted by country and study design.

SAG = sodium antimony gluconate; SSG = Sodium stibogluconate; L-AmB = Liposomal Amphotericin B; AMBd = Amphotericin B deoxycholate.
Fabiana Alves (217602), Eli Harriss (5636576), Prabin Dahal (3628118), Brittany J. Maguire (10492519), Rutuja Chhajed (18389750), Abdalla Munir (8988518), Caitlin Naylor (553871), Kasia Stepniewska (74266), Rishikesh Kumar (2142277), Shyam Sundar (58354), Niyamat Ali Siddiqui (3545723), Philippe J. Guerin (7464971), Sauman Singh-Phulgenda (10312644), Ahmed Musa (156973), Manju Rahi (6431396), Sumayyah Rashan (10492525), Krishna Pandey (567511)   +16 more
core   +1 more source

Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani [PDF]

, 2007
Objectives: The resistance of clinical isolates of Leishmania donovani to sodium antimony gluconate (SAG), the mainstay of treatment in Indian visceral leishmaniasis, has become a critical issue in India.
Singh, Sushma, Mukherjee, Angana, Padmanabhan, Prasad K., Girard, Isabelle, Chatterjee, Mitali, Roy, Gaetan, Madhubala, Rentala, Ouellette, Marc   +7 more
core   +1 more source

Inhibition of ABC transporters abolishes antimony resistance in leishmania infection

, 2008
The emergence of antimony (Sb) resistance has jeopardized the treatment of visceral leishmaniasis in various countries. Previous studies have considered the part played by leishmanial parasites in antimony resistance, but the involvement of host factors ...
Basu, Jayati Mookerjee, Saha, Manik, Naskar, Ksudiram, Sinha, Prabhat K., Banerjee, Rajdeep, et, al., Tripathy, Gayetri, Pandey, Krishna, Sundar, Shyam, Mookerjee, Ananda, Singh, Subhankar   +10 more
core   +1 more source

Synthesis of a Novel Quinoline Derivative, 2-(2-Methylquinolin-4- ylamino)-N-phenylacetamide—A Potential Antileishmanial Agent

, 2002
Some novel quinoline derivatives were prepared and tested for antileishmanial activity. 2-(2-Methylquinolin-4-ylamino)- N-phenylacetamide (2) was found to be significantly more active than the standard antileishmanial drug sodium antimony gluconate ...
Sahu, N, Sahu, Niranjan P, Mondal, Nirup B, Ghosh, Monidipa, Roy, Keshab, Mandal, Nirup B., Basu, Anirban, Kundu, Ashis P., Banerjee, Sukdeb, Raha, Mausumi, Kundu, Ashis P, Bandyopadhyay, Santu, Pal, Chiranjib   +12 more
core   +1 more source

Therapeutic trial of sodium antimony gluconate alone and in combination with ketoconazole in post-kala-azar dermal leishmaniasis (PKDL)

, 2003
Drugs used in PKDL include parenteral sodium antimony gluconate (SAG), amphotericin-B, pentamidine, and ketoconazole (KTZ). SAG is the most effective one.
R. K. Pandhi, P. Chopra, S. K. Rathi, N. Khanna   +3 more
core  

Summary of results from IgG1 rapid diagnostic tests (RDT) prototypes.

, 2014
aTherapy: sodium antimony gluconate n = 8; miltefosine n = 10; amphotericin B n = 3; combination therapy n = 2.b22 of these samples were also used with prototype 1.cthese samples were also negative with prototype 1.dthese 5 samples were also used with ...
Marissa A. Gripenberg (650430), Marleen Boelaert (56961), Pascal Mertens (263437), Duncan E. Bowes (524941), Om Prakash Singh (125511), Rajiv Kumar (117613), Armon Ayandeh (650429), Caroline Thunissen (650431), Sayda El-Safi (241936), Michael A. Miles (43726), Shyam Sundar (58354), Osama Eisa (650432), Alfarazdeg Saad (650433), Tapan Bhattacharyya (172083), Andrew K. Falconar (524942), Sara Silva Pereira (650434), Osman Ahmed (524943)   +16 more
core   +1 more source